These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2547298)

  • 1. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection.
    McDonald K; Rector TS; Braulin EA; Kubo SH; Olivari MT
    Am J Cardiol; 1989 Aug; 64(5):359-62. PubMed ID: 2547298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
    Gajarski RJ; Smith EO; Denfield SW; Rosenblatt HM; Kearney D; Frazier OH; Radovancevic B; Price JK; Kertesz NJ; Towbin JA
    Transplantation; 1998 Jun; 65(11):1470-6. PubMed ID: 9645805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.
    Olivari MT; Homans DC; Wilson RF; Kubo SH; Ring WS
    Circulation; 1989 Nov; 80(5 Pt 2):III111-5. PubMed ID: 2805289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease in pediatric cardiac transplant recipients receiving triple-drug immunosuppression.
    Braunlin EA; Hunter DW; Canter CE; Gutierrez FR; Ring WS; Olivari MT; Titus JL; Spray TL; Bolman RM
    Circulation; 1991 Nov; 84(5 Suppl):III303-9. PubMed ID: 1657452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
    Addonizio LJ; Hsu DT; Douglas JF; Kichuk MR; Michler RE; Quaegebeur JM; Smith CR; Rose EA
    Circulation; 1993 Nov; 88(5 Pt 2):II224-9. PubMed ID: 8222158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of coronary artery disease after heart transplantation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels.
    Gamba A; Mamprin F; Fiocchi R; Senni M; Troise G; Ferrazzi P; Ferrara R; Corbetta G
    Clin Cardiol; 1997 Sep; 20(9):767-72. PubMed ID: 9294668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
    Olivari MT; Kubo SH; Braunlin EA; Bolman RM; Ring WS
    Circulation; 1990 Nov; 82(5 Suppl):IV276-80. PubMed ID: 2225416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients.
    Radovancevic B; Poindexter S; Birovljev S; Velebit V; McAllister HA; Duncan JM; Vega D; Lonquist J; Burnett CM; Frazier OH
    Eur J Cardiothorac Surg; 1990; 4(6):309-12; discussion 313. PubMed ID: 2361019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease.
    Brunner-La Rocca HP; Schneider J; Künzli A; Turina M; Kiowski W
    Transplantation; 1998 Feb; 65(4):538-43. PubMed ID: 9500630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus infection.
    Normann SJ; Salomon DR; Leelachaikul P; Khan SR; Staples ED; Alexander JA; Mayfield WR; Knauf DG; Sadler LA; Selman S
    J Heart Lung Transplant; 1991; 10(5 Pt 1):674-87. PubMed ID: 1659903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of transplant coronary artery disease in Chinese heart recipients.
    Hsu RB; Chu SH; Wang SS; Ko WJ; Chou NK; Lee CM; Chen MF; Lee YT
    J Am Coll Cardiol; 1999 May; 33(6):1573-7. PubMed ID: 10334426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
    Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
    BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term development of transplant-related coronary artery disease in orthotopic cardiac allograft recipients.
    Albat B; Missov E; Serre I; Baldet P; Chaptal PA
    Minerva Cardioangiol; 1995 Oct; 43(10):435-8. PubMed ID: 8819811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection in heart transplantation: A single center experience.
    Echenique IA; Angarone MP; Rich JD; Anderson AS; Stosor V
    Transpl Infect Dis; 2018 Aug; 20(4):e12896. PubMed ID: 29602266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.
    Grattan MT; Moreno-Cabral CE; Starnes VA; Oyer PE; Stinson EB; Shumway NE
    JAMA; 1989 Jun 23-30; 261(24):3561-6. PubMed ID: 2542633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.